A single mutation supercharged its spread just as it reached Sierra ... This time, Sierra Leone isn’t waiting for others to step in to do testing and sequencing—it’s leading. Within days of the ...

Retail investor chatter around Incyte rose sharply on Sunday after the biotech firm announced a precision medicine collaboration with Qiagen and released encouraging early data on its experimental ...

QIAGEN N.V. QGEN recently announced a new global collaboration with Incyte INCY. The partnership enhances QIAGEN’s onco-hematology diagnostics pipeline and supports Incyte’s extensive portfolio in ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) have announced a global collaboration to create a next-generation sequencing (NGS) diagnostic ...

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X ...

Illumina, Inc. will acquire SomaLogic for $350 million plus performance-based milestones. The acquisition advances Illumina's multiomics strategy, combining SomaLogic's proteomics technology with ...

Illumina inked a deal with Standard BioTools to acquire SomaLogic for $350 million in cash. The maker of gene-sequencing equipment and services said Monday that the deal includes an additional payout ...

From the time we are conceived and through old age, genetic mutations accumulate in all our tissues, eluding the body's ...